Suppr超能文献

[肌萎缩侧索硬化症患者的夜间血氧饱和度测定:对预测生存率的作用]

[Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival].

作者信息

Velasco R, Salachas F, Munerati E, Le Forestier N, Pradat P F, Lacomblez L, Orvoen Frija E, Meininger V

机构信息

Assistance Publique-Hôpitaux de Paris: Fédération de Neurologie Mazarin, Hôpital de la Salpêtrière, Paris, France.

出版信息

Rev Neurol (Paris). 2002 May;158(5 Pt 1):575-8.

Abstract

Death is the most important end point along the course of amyotrophic lateral sclerosis (ALS). It is commonly attributed to a respiratory failure in relation with a restrictive respiratory disorder. However, in clinical practice, it is frequent to observe that death has not direct relation with the values of the respiratory function, at least measured with vital capacity. It is also frequent that relatives report sudden death during nocturnal sleep. All these features raised the question of the possible relation between death and nocturnal oxymetry in ALS patients. In a prospective study, we studied 69 ALS patients. We recorded demographic data, clinical parameters as manual muscle testing and functional scales, various parameters of oxymetry measured by pulse oxymetry recorded during night, slow vital capacity and survival time. There is a strong correlation between survival time measured by Kaplan Meier curves and log rank and the mean nocturnal saturation. We determined 93 mmHg as a threshold value. Below this threshold, mean survival time was 7.5+/-1.6 months and above it was equal to 18.5+/-1.5; relative risk was 3.31. These data confirm the importance of nocturnal oxymetry on survival in ALS patients both in clinical practice and in view of therapeutic trials.

摘要

死亡是肌萎缩侧索硬化症(ALS)病程中最重要的终点。死亡通常归因于与限制性呼吸障碍相关的呼吸衰竭。然而,在临床实践中,经常观察到死亡与呼吸功能值没有直接关系,至少用肺活量测量时是这样。亲属报告患者在夜间睡眠中突然死亡的情况也很常见。所有这些特征都引发了关于ALS患者死亡与夜间血氧饱和度测定之间可能存在的关系的问题。在一项前瞻性研究中,我们对69例ALS患者进行了研究。我们记录了人口统计学数据、临床参数(如徒手肌力测试和功能量表)、夜间通过脉搏血氧饱和度测定测得的各种血氧饱和度参数、慢肺活量和生存时间。通过Kaplan Meier曲线和对数秩检验测得的生存时间与夜间平均血氧饱和度之间存在很强的相关性。我们确定93mmHg为阈值。低于该阈值时,平均生存时间为7.5±1.6个月,高于该阈值时为18.5±1.5个月;相对风险为3.31。这些数据证实了夜间血氧饱和度测定在临床实践和治疗试验中对ALS患者生存的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验